Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Sodium chloride; Potassium chloride; Calcium chloride dihydrate ; Sodium lactate solution 50%
Fresenius Kabi Limited
B05BB; B05BB01
Sodium chloride; Potassium chloride; Calcium chloride dihydrate ; Sodium lactate solution 50%
percent volume/volume
Solution for infusion
Product subject to prescription which may not be renewed (A)
Solutions affecting the electrolyte balance; electrolytes
Not marketed
2005-05-20
6 5 The following information is intended for medical or healthcare professionals only: Warnings This solution must not be given by intramuscular injection. Keep to a slow infusion rate. The infusion must be stopped if any abnormal sign develops. Risk of complications related to volume and amount of electrolytes administered. Risk of overload of cardiovascular system with pulmonary oedema, especially in predisposed individuals. Infusion of Hartmann's Solution may cause metabolic alkalosis because of the presence of lactate ions. Hartmann’s Solution may not produce its alkalinizing action in patients with hepatocellular insufficiency since lactate metabolism may be impaired. In case of concomitant blood transfusion and because of the presence of calcium, Hartmann's Solution must not be administered via the same infusion system because of the risk of coagulation. Precautions for use The patient's clinical status and laboratory parameters (blood and urine electrolytes) must be monitored during use of this solution, especially in the following situations: • congestive cardiac failure, • severely impaired renal function, • oedema with sodium retention. Precautions for using bag • do not use an air entry • flush the infusion system in order to avoid any passage of air • do not connect in series since the residual of the first container might be carried on by the solution coming from the second container, with the risk of air embolism. • for single use only; do not reconnect partially used container. Physico-chemical incompatibilities: It is up to the physician to determine the incompatibility of an added medicine regarding Hartmann's Solution, by checking for any possible colour change and/or possible formation of precipitate, insoluble complex or crystals. There is physical-chemical incompatibility with certain antibiotics when they are given intravenously: chlortetracycline, amphotericin B, oxytetracycline. Before adding any medicine, check that the pH zone in which it is effective corresponds to that Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Hartmann’s Solution for Infusion, PPC PSEB bag. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For full list of excipients, see section 6.1. Molar formula 3 PHARMACEUTICAL FORM Solution for infusion. Osmolarity: 279 mOsm/l Osmolarity: 255 mOsm/kg pH: 5.5 to 6.3 Clear colourless solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS - Predominantly extracellular dehydration, regardless of cause (vomiting, diarrhea, fistulas, etc.). - Hypovolemia regardless of cause: hemorrhagic shock, burns, peri-operative water and electrolyte loss. - Mild metabolic acidosis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY : This is determined by the physician according to clinical status, age and weight of the patient and according to laboratory findings. METHOD OF ADMINISTRATION : This solution must be given by slow intravenous infusion under strictly aseptic conditions. Bag : 50 ml 100 ml 250 ml 500 ml 1000 ml Sodium chloride (g) 0.30 0.60 1.50 3.00 6.00 Potassium chloride (g) 0.02 0.04 0.10 0.20 0.40 Dihydrated calcium chloride (g) 0.01 0.03 0.07 0.14 0.27 50% sodium lactate solution (g) 0.32 0.63 1.59 3.17 6.34 Bag : 50 ml 100 ml 250 ml 500 ml 1000 ml Sodium (mmol) 6.55 13.09 32.73 65.45 130.90 Potassium (mmol) 0.27 0.54 1.35 2.70 5.40 Calcium (mmol) 0.09 0.18 0.46 0.92 1.84 Chloride (mmol) 5.59 11.17 27.93 55.85 111.70 Lactate (mmol) 1.42 2.83 7.08 14.15 28.30 H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _2_ _/_ Read the complete document